Literature DB >> 18414777

Impact of state and trait anxiety on the panic response to CCK-4.

Daniela Eser1, Stephan Wenninger, Thomas Baghai, Cornelius Schüle, Rainer Rupprecht.   

Abstract

In order to elucidate the impact of psychological factors on panic severity the correlation between baseline anxiety and panic response to cholecystokinin-tetrapeptide (CCK-4), an established model of human anxiety, was investigated in 33 healthy volunteers. Baseline anxiety was assessed with the State-Trait-Anxiety-Inventory (STAI). Trait and state anxiety did not differ between panickers and nonpanickers nor were they correlated with panic severity. In conclusion, psychological factors are not major determinants for the subjective panic response to CCK-4 thus emphasising the importance of neurobiological factors.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18414777     DOI： 10.1007/s00702-008-0047-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN： 0300-9564            Impact factor:   3.575


  27 in total

1.  Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.

Authors:  D Koszycki; R M Zacharko; J M Le Mellédo; J Bradwejn
Journal:  Depress Anxiety       Date:  1998       Impact factor: 6.505

2.  Is anxiety sensitivity distinguishable from trait anxiety? Reply to Lilienfeld, Jacob, and Turner (1989).

Authors:  R J McNally
Journal:  J Abnorm Psychol       Date:  1989-05

3.  Influence of personality on behavioral response to cholecystokinin-tetrapeptide in patients with panic disorder.

Authors:  D Koszycki; R M Zacharko; J Bradwejn
Journal:  Psychiatry Res       Date:  1996-05-17       Impact factor: 3.222

4.  A cognitive approach to panic.

Authors:  D M Clark
Journal:  Behav Res Ther       Date:  1986

5.  Effect of acute tryptophan depletion on behavioral, cardiovascular, and hormonal sensitivity to cholecystokinin-tetrapeptide challenge in healthy volunteers.

Authors:  D Koszycki; R M Zacharko; J M Le Melledo; S N Young; J Bradwejn
Journal:  Biol Psychiatry       Date:  1996-10-01       Impact factor: 13.382

Review 6.  Anxiety sensitivity and panic disorder.

Authors:  Richard J McNally
Journal:  Biol Psychiatry       Date:  2002-11-15       Impact factor: 13.382

Review 7.  Trait anxiety: it's not what you think it is.

Authors:  S Reiss
Journal:  J Anxiety Disord       Date:  1997 Mar-Apr

8.  Effects of alprazolam on cholecystokinin-tetrapeptide-induced panic and hypothalamic-pituitary-adrenal-axis activity: a placebo-controlled study.

Authors:  P Zwanzger; D Eser; S Aicher; C Schüle; T C Baghai; F Padberg; R Ella; H-J Möller; R Rupprecht
Journal:  Neuropsychopharmacology       Date:  2003-03-26       Impact factor: 7.853

9.  Emotional and cognitive factors connected with response to cholecystokinin tetrapeptide in healthy volunteers.

Authors:  A Aluoja; J Shlik; V Vasar; P H Kingisepp; K Jagomägi; E Vasar; J Bradwejn
Journal:  Psychiatry Res       Date:  1997-01-15       Impact factor: 3.222

10.  Anxiety sensitivity and response to cholecystokinin tetrapeptide in healthy volunteers.

Authors:  D Koszycki; B J Cox; J Bradwejn
Journal:  Am J Psychiatry       Date:  1993-12       Impact factor: 18.112
View more
  3 in total

Review 1.  Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition.

Authors:  Borwin Bandelow; David Baldwin; Marianna Abelli; Blanca Bolea-Alamanac; Michel Bourin; Samuel R Chamberlain; Eduardo Cinosi; Simon Davies; Katharina Domschke; Naomi Fineberg; Edna Grünblatt; Marek Jarema; Yong-Ku Kim; Eduard Maron; Vasileios Masdrakis; Olya Mikova; David Nutt; Stefano Pallanti; Stefano Pini; Andreas Ströhle; Florence Thibaut; Matilde M Vaghi; Eunsoo Won; Dirk Wedekind; Adam Wichniak; Jade Woolley; Peter Zwanzger; Peter Riederer
Journal:  World J Biol Psychiatry       Date:  2016-07-15       Impact factor: 4.132

2.  Blockade of the cholecystokinin CCK-2 receptor prevents the normalization of anxiety levels in the rat.

Authors:  Santiago J Ballaz; Michel Bourin; Huda Akil; Stanley J Watson
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-09-14       Impact factor: 5.067

Review 3.  Neuroimaging in anxiety disorders.

Authors:  Kathrin Holzschneider; Christoph Mulert
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.